PAPER O'Donovan J, Watson R, Colloby SJ, Firbank MJ, Burton EJ, Barber R, Blamire AM, O'Brien JT
SEARCH RESULTS
331159 RESULTS
PAPER Mukaetova-Ladinska EB, Abdel-All Z, Andrade J, McNally RJ, James PW, Kalaria RN, O'Brien JT
Increase in Platelet Immunoglobulin in Alzheimer's Disease is Normalised Following Cholinesterase Inhibitor Treatment: Preliminary Results.
J Alzheimers Dis. 2012 Jan 1;32(2):431-6. PubMed: 22810090PAPER Hashimoto G, Sakurai M, Teich AF, Saeed F, Aziz F, Arancio O
5-HT4 Receptor Stimulation Leads to Soluble AβPPα Production Through MMP-9 Upregulation.
J Alzheimers Dis. 2012 Jan 1;32(2):437-45. PubMed: 22810092PAPER Wu J, Yang J, Yu Y, Li Q, Nakamura N, Shen Y, Ohta Y, Yu S, Abe K
Delayed audiovisual integration of patients with mild cognitive impairment and Alzheimer's disease compared with normal aged controls.
J Alzheimers Dis. 2012 Jan 1;32(2):317-28. PubMed: 22810093PAPER Toda N, Okamura T
Cerebral Blood Flow Regulation by Nitric Oxide in Alzheimer's Disease.
J Alzheimers Dis. 2012 Jul 17; PubMed: 22810094PAPER Flores B, von Bernhardi R
Transforming Growth Factor β1 Modulates Amyloid β-Induced Glial Activation through the Smad3-Dependent Induction of MAPK Phosphatase-1.
J Alzheimers Dis. 2012 Jan 1;32(2):417-29. PubMed: 22810097PAPER Kennelly S, Collins O
Walking the Cognitive "Minefield" between High and Low Blood Pressure.
J Alzheimers Dis. 2012 Jul 17; PubMed: 22810098PAPER Mandal PK, Joshi J, Saharan S
Visuospatial perception: an emerging biomarker for Alzheimer's disease.
J Alzheimers Dis. 2012;31 Suppl:S117-35. PubMed: 22810101PAPER Ubhi K, Masliah E
Alzheimer's disease: recent advances and future perspectives.
J Alzheimers Dis. 2013;33 Suppl 1:S185-94. PubMed: 22810100PAPER Bialopiotrowicz E, Szybinska A, Kuzniewska B, Buizza L, Uberti D, Kuznicki J, Wojda U
Highly Pathogenic Alzheimer's Disease Presenilin 1 P117R Mutation Causes a specific Increase in p53 and p21 Protein Levels and Cell Cycle Dysregulation in Human Lymphocytes.
J Alzheimers Dis. 2012 Jan 1;32(2):397-415. PubMed: 22810102PAPER Arendash GW
Transcranial Electromagnetic Treatment Against Alzheimer's Disease: Why it has the Potential to Trump Alzheimer's Disease Drug Development.
J Alzheimers Dis. 2012 Jan 1;32(2):243-66. PubMed: 22810103PAPER Graff-Radford J, Boeve BF, Pedraza O, Ferman TJ, Przybelski S, Lesnick TG, Vemuri P, Senjem ML, Smith GE, Knopman DS, Lowe V, Jack CR, Petersen RC, Kantarci K
Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
Brain. 2012 Aug;135(Pt 8):2470-7. PubMed: 22810436PAPER Hernández-Ortega K, Arias C
ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion.
J Neurosci Res. 2012 Nov;90(11):2116-26. PubMed: 22811014PAPER Vadnal J, Houston S, Bhatta S, Freeman E, McDonough J
Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.
Exp Brain Res. 2012 Sep;221(3):287-97. PubMed: 22811216PAPER Yamaguchi T, Maki Y, Yamaguchi H
Yamaguchi Facial Expression-Making Task in Alzheimer's Disease: A Novel and Enjoyable Make-a-Face Game.
Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):248-57. PubMed: 22811688Current Filters
No filters selected